Home » Authors » Kim Coghill

Articles by Kim Coghill

Enanta Gets Partner For Antibiotic In Japan, East Asia, Seeks Others

July 28, 2004

Inspire Raises $72M In Public Offering To Advance Drugs

July 28, 2004

Inspire Pharmaceuticals Inc. raised $72 million in a follow-on offering of 6 million shares of common stock at a price of $12 per share. (BioWorld Today)

Enanta Gets Partner For Antibiotic In Japan, East Asia, Seeks Others

July 28, 2004

Inspire Raises $72M In Public Offering To Advance Drugs

July 28, 2004

Inspire Pharmaceuticals Inc. raised $72 million in a follow-on offering of 6 million shares of common stock at a price of $12 per share. (BioWorld Today)

Comparison Study Earns Amylin $5M Milestone Payment From Lilly

July 27, 2004

Comparison Study Earns Amylin $5M Milestone Payment From Lilly

July 27, 2004

Hudson Health Gains Listing Via Reverse Merger, Raises $8M

July 26, 2004

Tapestry Calls On Supratek To Help Develop New Formulations

July 26, 2004

Hudson Health Gains Listing Via Reverse Merger, Raises $8M

July 26, 2004

Tapestry Calls On Supratek To Help Develop New Formulations

July 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...